Hosted by the DNB//Back Bay Healthcare Partnership, the NAHC unites large and mid-cap public and private IPO-ready US and Nordic life science companies. 

Participating companies showcase leading products that offer substantial advancements in patient care, making them highly appealing investment opportunities. 

Thanks to the many US healthcare investors and US and Nordic companies who participated in the NAHC 2025. The event was extremely well-received and fully booked in 2025.

Registration for NAHC 2026 will open this summer.

To learn more about the presentation criteria for presenting , or to request advance booking for institutional investors, please be in touch.